These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32588535)

  • 1. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states.
    Thachil J
    J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both.
    Levi M; Thachil J
    Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
    Miesbach W; Makris M
    Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
    Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
    Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
    Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
    Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
    Ahmed S; Zimba O; Gasparyan AY
    Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 coagulopathy vs disseminated intravascular coagulation.
    Levi M
    Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
    Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
    Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19).
    Salamanna F; Maglio M; Landini MP; Fini M
    Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
    Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
    Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.
    Pooni RS
    Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158
    [No Abstract]   [Full Text] [Related]  

  • 13. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability.
    Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ
    Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 coagulopathy: an evolving story.
    The Lancet Haematology
    Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
    [No Abstract]   [Full Text] [Related]  

  • 15. Hematological findings and complications of COVID-19.
    Terpos E; Ntanasis-Stathopoulos I; Elalamy I; Kastritis E; Sergentanis TN; Politou M; Psaltopoulou T; Gerotziafas G; Dimopoulos MA
    Am J Hematol; 2020 Jul; 95(7):834-847. PubMed ID: 32282949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19).
    Parra-Izquierdo I; Aslan JE
    Semin Thromb Hemost; 2020 Oct; 46(7):826-830. PubMed ID: 32882716
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.
    Frydman GH; Boyer EW; Nazarian RM; Van Cott EM; Piazza G
    Clin Appl Thromb Hemost; 2020; 26():1076029620943671. PubMed ID: 32702995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe COVID-19 infection associated with endothelial activation.
    Escher R; Breakey N; Lämmle B
    Thromb Res; 2020 Jun; 190():62. PubMed ID: 32305740
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune-Mediated Coagulopathy in COVID-19 Infection.
    Vadasz Z; Brenner B; Toubi E
    Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.